1.
Li F, Ma W. Study on the Impact of the Centralized Procurement Policy for Traditional Chinese Patent Medicines on the Innovation Performance of Listed Traditional Chinese Medicine Enterprises in China. SJEMR [Internet]. 2026 Jun. 4 [cited 2026 Jun. 18];8(6):1-10. Available from: https://bcpublication.org/index.php/SJEMR/article/view/9416